scPharmaceuticals, Inc. IPO Research Information

scPharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on scPharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
scPharmaceuticals, Inc.	SCPH - NASDAQ	$14.00-$16.00	$14.00	$14.25	6.4 million	11/17/2017
Underwriter(s): Jefferies, Leerink, BMO Capital Markets
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2017-10-23 Terms Added 2017-11-07 Final Prospectus 2017-11-17

scPharmaceuticals, Inc. Quote & Chart - Click for current quote - SCPH

About scPharmaceuticals, Inc. (adapted from scPharmaceuticals, Inc. prospectus):
They are a pharmaceutical company focused on developing and commercializing products that have the potential to transform the way therapy is delivered, advance patient care and reduce healthcare costs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "SCPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.